SELDI-TOF-MS Profiling of Metastatic Phenotype in Histopathological Subtypes of Breast Cancer

Creative Commons License

Yiğitbaşı T., Çalıbaşı Koçal G., Buyukuslu N., Atahan M. K., Kupeli H., Yigit S., ...Daha Fazla

CURRENT PROTEOMICS, cilt.15, sa.3, ss.214-220, 2018 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2174/1570164615666180309154038
  • Dergi Adı: CURRENT PROTEOMICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.214-220
  • Anahtar Kelimeler: Breast cancer, histopathological subtypes, SELDI-TOF-MS, profiling, serum proteome, metastatic phenotype, SERUM BIOMARKERS, PROTEOMICS, DISCOVERY, DIAGNOSIS, TECHNOLOGY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Early detection of breast cancer is a key to the success of breast cancer management. Serum proteome analysis using Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (SELDI-TOF-MS) generates useful information that can be utilized to describe exclusive prognostic and diagnostic biomarkers.